New treatment option for Malnutrition
Official title Improving Nutritional Adequacy of ICU Survivors in a Prospective Interventional Way: the Bright Side Study
ClinicalTrials.gov ID: NCT06023251
What this study is testing
- What it's testing
- The objective is to increase caloric adequacy in patients who survived critical illness and are admitted to the ward by the use of a pro-active inclusive nutritional strategy including supplemental parenteral and/or enteral nutrition and/or oral nutritional supplements guided by indirect calorimetry. This enables the investigators to address, within a clinical/scientific context, a recently demonstrated but until now relatively neglected 'dark side' of patient care at UZ Brussel, comparable to limited global evidence : iatrogenic malnutrition of ICU survivors.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult ≥ 18 years
- ICU stay ≥ 7 days
- Ward stay ≥ 3 days
- Nutritional therapy not restricted
- Heterogeneous diseases
You likely can't join if
- Patients \< 18 years
- ICU \< 7 days
- Ward stay \< 3 days
- Advanced Care Planning with impact on nutritional therapy
- Patients with palliative care
- Metabolic derangements such as metabolic diseases
See the full eligibility criteria
- Adult ≥ 18 years
- ICU stay ≥ 7 days
- Ward stay ≥ 3 days
- Nutritional therapy not restricted
- Heterogeneous diseases
- Patients \< 18 years
- ICU \< 7 days
- Ward stay \< 3 days
- Advanced Care Planning with impact on nutritional therapy
- Patients with palliative care
- Metabolic derangements such as metabolic diseases
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Brussels, Belgium
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brussels, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.